Pharmafile Logo
Pharmafocus logo
Advanced Search

GENFIT

Showing 1 posts of 1 posts found.

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025
Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

News
The Gateway to Local Adoption Series

Latest content

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026

AbbVie expands Oxford R&D facility with new £120m UK research commitment

November 9, 2026

MedPharm appoints Jason Mieding as chief operating officer

November 8, 2026

UKRI backs five hubs developing AI tools for earlier disease detection

November 8, 2026

Coriolis Pharma appoints Teun van der Heide as CEO

November 7, 2026